The effect of preoperative nutritional status on postoperative outcomes in children undergoing surgery for congenital heart defects in San Francisco (UCSF) and Guatemala City (UNICAR)

J Thorac Cardiovasc Surg. 2014 Jan;147(1):442-50. doi: 10.1016/j.jtcvs.2013.03.023. Epub 2013 Apr 9.

Abstract

Objective: The objective of this study was to determine the association between preoperative nutritional status and postoperative outcomes in children undergoing surgery for congenital heart defects (CHD).

Methods: Seventy-one patients with CHD were enrolled in a prospective, 2-center cohort study. We adjusted for baseline risk differences using a standardized risk adjustment score for surgery for CHD. We assigned a World Health Organization z score for each subject's preoperative triceps skin-fold measurement, an assessment of total body fat mass. We obtained preoperative plasma concentrations of markers of nutritional status (prealbumin, albumin) and myocardial stress (B-type natriuretic peptide [BNP]). Associations between indices of preoperative nutritional status and clinical outcomes were sought.

Results: Subjects had a median (interquartile range [IQR]) age of 10.2 (33) months. In the University of California at San Francisco (UCSF) cohort, duration of mechanical ventilation (median, 19 hours; IQR, 29 hours), length of intensive care unit stay (median, 5 days; IQR 5 days), duration of any continuous inotropic infusion (median, 66 hours; IQR 72 hours), and preoperative BNP levels (median, 30 pg/mL; IQR, 75 pg/mL) were associated with a lower preoperative triceps skin-fold z score (P < .05). Longer duration of any continuous inotropic infusion and higher preoperative BNP levels were also associated with lower preoperative prealbumin (12.1 ± 0.5 mg/dL) and albumin (3.2 ± 0.1; P < .05) levels.

Conclusions: Lower total body fat mass and acute and chronic malnourishment are associated with worse clinical outcomes in children undergoing surgery for CHD at UCSF, a resource-abundant institution. There is an inverse correlation between total body fat mass and BNP levels. Duration of inotropic support and BNP increase concomitantly as measures of nutritional status decrease, supporting the hypothesis that malnourishment is associated with decreased myocardial function.

Keywords: 18; 20; 21; B-type natriuretic peptide; BMI; BNP; CHD; CI; CPB; ICU; LOS; La Unidad de Cirugia Cardiovascular de Guatemala; PCICU; TSFZ; UCSF; UNICAR; University of California at San Francisco; WHO; World Health Organization; body mass index; cardiopulmonary bypass; confidence interval; congenital heart disease; intensive care unit; length of stay; pediatric cardiac intensive care unit; triceps skin-fold-for-age z score.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adiposity
  • Biomarkers / blood
  • Cardiac Surgical Procedures / adverse effects*
  • Cardiac Surgical Procedures / mortality
  • Cardiotonic Agents / therapeutic use
  • Child Nutrition Disorders / complications*
  • Child Nutrition Disorders / diagnosis
  • Child Nutrition Disorders / mortality
  • Child Nutrition Disorders / physiopathology
  • Child Nutritional Physiological Phenomena*
  • Child, Preschool
  • Female
  • Guatemala
  • Heart Defects, Congenital / complications
  • Heart Defects, Congenital / diagnosis
  • Heart Defects, Congenital / physiopathology
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant
  • Infant Nutrition Disorders / complications*
  • Infant Nutrition Disorders / diagnosis
  • Infant Nutrition Disorders / mortality
  • Infant Nutrition Disorders / physiopathology
  • Infant, Newborn
  • Length of Stay
  • Linear Models
  • Logistic Models
  • Male
  • Malnutrition / complications*
  • Malnutrition / diagnosis
  • Malnutrition / mortality
  • Malnutrition / physiopathology
  • Multivariate Analysis
  • Natriuretic Peptide, Brain / blood
  • Nutritional Status*
  • Pilot Projects
  • Postoperative Complications / etiology*
  • Postoperative Complications / mortality
  • Postoperative Complications / therapy
  • Prealbumin / analysis
  • Prospective Studies
  • Respiration, Artificial
  • Risk Factors
  • San Francisco
  • Serum Albumin / analysis
  • Serum Albumin, Human
  • Skinfold Thickness
  • Time Factors
  • Treatment Outcome

Substances

  • ALB protein, human
  • Biomarkers
  • Cardiotonic Agents
  • Prealbumin
  • Serum Albumin
  • Natriuretic Peptide, Brain
  • Serum Albumin, Human